Paper39436655
eIF4F controls ERK MAPK signaling in melanomas with BRAF and NRAS mutations.
Valcikova B and 14 others. Proc Natl Acad Sci U S A, 2024. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. eIF4F controls ERK MAPK signaling in melanomas with BRAF and NRAS mutations. Papers, record 39436655. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39436655
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Eukaryotic Initiation Factor-4F | Major topic |
| GTP Phosphohydrolases | Major topic |
| MAP Kinase Signaling System | Major topic |
| Melanoma | Major topic |
| Membrane Proteins | Major topic |
| Mutation | Major topic |
| Proto-Oncogene Proteins B-raf | Major topic |
| Animals | |
| Humans | |
| Mice | |
| Cell Line, Tumor | |
| Dual Specificity Phosphatase 6 | |
| Extracellular Signal-Regulated MAP Kinases | |
| Eukaryotic Initiation Factor-4E |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| LX22NPO5102 | European Commission (EC) | PubMed | ||
| 18/SPP/3522 | Science Foundation Ireland (SFI) | PubMed | ||
| GA22-30397S | Grantová Agentura České Republiky (GAČR) | PubMed | ||
| CZ.02.1.01/0.0/0.0/16_019/0000868 | EC | European Regional Development Fund (ERDF) | PubMed | ||
| 208402/Z/17 | Wellcome Trust (WT) | PubMed | ||
| Wellcome Trust | United Kingdom | PubMed | ||
| GA20-22984S | Grantová Agentura České Republiky (GAČR) | PubMed |
Source PubMed
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27533468 | Synergistic effects of eIF4A and MEK inhibitors on proliferation of NRAS-mutant melanoma cell lines. | Cell Cycle | 2016 | https://conductscience.org/library/papers/27533468 | PubMed |
| 2 | 9155017 | Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. | EMBO J | 1997 | https://conductscience.org/library/papers/9155017 | PubMed |
| 3 | 25079330 | eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies. | Nature | 2014 | https://conductscience.org/library/papers/25079330 | PubMed |
| 4 | 28910386 | DUSP5 and DUSP6, two ERK specific phosphatases, are markers of a higher MAPK signaling activation in BRAF mutated thyroid cancers. | PLoS One | 2017 | https://conductscience.org/library/papers/28910386 | PubMed |
| 5 | 26603897 | SBI-0640756 Attenuates the Growth of Clinically Unresponsive Melanomas by Disrupting the eIF4F Translation Initiation Complex. | Cancer Res | 2015 | https://conductscience.org/library/papers/26603897 | PubMed |
| 6 | 34857952 | Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers. | Nat Genet | 2021 | https://conductscience.org/library/papers/34857952 | PubMed |
| 7 | 31723131 | eIF4A supports an oncogenic translation program in pancreatic ductal adenocarcinoma. | Nat Commun | 2019 | https://conductscience.org/library/papers/31723131 | PubMed |
| 8 | 25743081 | Targeting the translation machinery in cancer. | Nat Rev Drug Discov | 2015 | https://conductscience.org/library/papers/25743081 | PubMed |
| 9 | 19251651 | (V600E)BRAF is associated with disabled feedback inhibition of RAF-MEK signaling and elevated transcriptional output of the pathway. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19251651 | PubMed |
| 10 | 30401534 | Dual-specificity MAP kinase phosphatases in health and disease. | Biochim Biophys Acta Mol Cell Res | 2019 | https://conductscience.org/library/papers/30401534 | PubMed |
| 11 | 18300768 | The MAPK pathway in melanoma. | Curr Opin Oncol | 2008 | https://conductscience.org/library/papers/18300768 | PubMed |
| 12 | 8766822 | Insulin-stimulated phosphorylation of initiation factor 4E is mediated by the MAP kinase pathway. | FEBS Lett | 1996 | https://conductscience.org/library/papers/8766822 | PubMed |
| 13 | 27309803 | Rocaglates convert DEAD-box protein eIF4A into a sequence-selective translational repressor. | Nature | 2016 | https://conductscience.org/library/papers/27309803 | PubMed |
| 14 | 31844050 | An epitranscriptomic mechanism underlies selective mRNA translation remodelling in melanoma persister cells. | Nat Commun | 2019 | https://conductscience.org/library/papers/31844050 | PubMed |
| 15 | 20215513 | Transcriptional pathway signatures predict MEK addiction and response to selumetinib (AZD6244). | Cancer Res | 2010 | https://conductscience.org/library/papers/20215513 | PubMed |
| 16 | 28199182 | One reporter for in-cell activity profiling of majority of protein kinase oncogenes. | Elife | 2017 | https://conductscience.org/library/papers/28199182 | PubMed |
| 17 | 18439900 | AMPK phosphorylation of raptor mediates a metabolic checkpoint. | Mol Cell | 2008 | https://conductscience.org/library/papers/18439900 | PubMed |
| 18 | 28923912 | Exploiting Drug Addiction Mechanisms to Select against MAPKi-Resistant Melanoma. | Cancer Discov | 2018 | https://conductscience.org/library/papers/28923912 | PubMed |
| 19 | 17018604 | In melanoma, RAS mutations are accompanied by switching signaling from BRAF to CRAF and disrupted cyclic AMP signaling. | Cancer Res | 2006 | https://conductscience.org/library/papers/17018604 | PubMed |
| 20 | 9878069 | Human eukaryotic translation initiation factor 4G (eIF4G) recruits mnk1 to phosphorylate eIF4E. | EMBO J | 1999 | https://conductscience.org/library/papers/9878069 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42850324 | Mapping the functional dark proteome in cancer. | Nat Rev Cancer | 2026 | https://conductscience.org/library/papers/42850324 | PubMed |
| 42707299 | Dual MAO A and HSP90 inhibitors enhance anti-PD-1 therapy and suppress colorectal cancer. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42707299 | PubMed |
| 42599619 | Molecular therapy for papillary craniopharyngioma: a multi-institutional analysis of practice patterns across the RAPID Consortium. | J Neurooncol | 2026 | https://conductscience.org/library/papers/42599619 | PubMed |
| 42519028 | The dual specificity phosphatase 2 act as distal regulatory node in T cell signaling. | iScience | 2026 | https://conductscience.org/library/papers/42519028 | PubMed |
| 42050705 | Translational control of AMPK activity in melanoma. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/42050705 | PubMed |
| 41865130 | ERKed by too much signaling: from oncogenic driver to therapeutic vulnerability. | Cell Mol Life Sci | 2026 | https://conductscience.org/library/papers/41865130 | PubMed |
| 41807883 | BRAF inhibitor resistance in melanoma: from resistance mechanisms to therapeutic innovations. | Mol Biomed | 2026 | https://conductscience.org/library/papers/41807883 | PubMed |
| 41799498 | Combinational Inhibition of the eIF4F Complex, AKT1, and EZH2 Enhances Anticancer Effects in BRAFV600E Mutant A375 Melanoma Cells. | Oncol Res | 2026 | https://conductscience.org/library/papers/41799498 | PubMed |
| 41754923 | Atlas-Guided Nanocarrier Strategies Targeting Spatial NTRK2/MAPK Signaling in EGFR-TKI-Resistant Niches of Esophageal Squamous Cell Carcinoma. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/41754923 | PubMed |
| 41648055 | Unveiling a BRAF Signature Proficient in Accurately Capturing Oncogenic Activity and Guiding Prognostic Prediction Across Multiple Cancers. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/41648055 | PubMed |
| 39809544 | eIF4F-mediated dysregulation of mRNA translation in cancer. | RNA | 2025 | https://conductscience.org/library/papers/39809544 | PubMed |
| 39436655 | eIF4F controls ERK MAPK signaling in melanomas with BRAF and NRAS mutations. | Proc Natl Acad Sci U S A | 2024 | https://conductscience.org/library/papers/39436655 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39436655
GET https://conductscience.org/api/papers/v1/39436655/references?page=2